Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lenacapavir (GS-6207) is a potent capsid-targeting inhibitor of HIV replication. Lenacapavir shows anti-HIV activity with an EC50 of 100 pM in MT-4 cells.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 76,500 |
5 mg | 在庫あり | ¥ 158,500 |
10 mg | 在庫あり | ¥ 259,500 |
25 mg | 在庫あり | ¥ 383,500 |
50 mg | 在庫あり | ¥ 516,500 |
100 mg | 在庫あり | ¥ 682,000 |
ターゲット&IC50 | MT-4 cells:100 pM (EC50), Anti-HIV:100 pM (EC50) |
別名 | GS-6207 |
分子量 | 968.28 |
分子式 | C39H32ClF10N7O5S2 |
CAS No. | 2189684-44-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 195 mg/mL (201.39 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lenacapavir 2189684-44-2 Microbiology/Virology Others Proteases/Proteasome HIV Protease MT-4 Inhibitor antiretroviral GS-6207 inhibit GS6207 capsid GS 6207 Human immunodeficiency virus HIV HIV-1 PBMCs inhibitor